Ovarian Stimulation Current Events | Ovarian Stimulation News | 3
|
| Page
3 of
20 |
381 Results |
|
|
|
Sort By:
Page Views | Date |
Electric Therapy helps Muscle Spasticity
Researchers in Austria who have been trying to overcome spasticity in people with spinal cord injury have made significant progress that might, in the future, help patients to stand. A technique called spinal cord stimulation is showing promise for people whose legs are bent and stiffened due to damaged nerves as a result of injury. Dr Michaela... view more... (2002-10-24)
Cancer cells lose drug resistance following electrical stimulation in vitro
Drug-resistant tumour cells lose their drug resistance when exposed to low intensity, low frequency electric pulses for three days. view more (2006-03-17)
Ovarian cancer responds to aspirin derivative with chemo
A new study using ovarian cancer cell lines shows promise in treating the deadly disease by combining the chemotherapy drug cisplatin with an aspirin-like compound to make recurrent cancer cells less resistant to the chemotherapy. view more (2006-02-16)
Getting Relief from Pain Can Be Shocking
People suffering from chronic pain caused by a nerve injury are experiencing relief through the use of electrical stimulation of the spinal cord. The journal Neuromodulation, published by Blackwell on behalf of the International Neuromodulation Society and the International Functional Electrical Stimulation Society, just released findings from a... view more... (2004-07-26)
Magnetic brain stimulation improves skill learning
The use of magnetic pulses to stimulate the dorsal premotor cortex (PMd) region of the brain results in an improved ability to learn a skilled motor task. view more (2009-07-07)
Study suggests chemotherapy diminishes fertility in breast cancer patients
Pre-menopausal breast cancer survivors who were treated with chemotherapy following surgery were more likely to have diminished ovarian reserve - the capacity of the ovaries to provide eggs capable of being fertilized - compared to women who have never had breast cancer, according to a study led by Dana-Farber Cancer Institute investigators. view more (2008-05-30)
First study of children born after in vitro maturation indicates the technique is safe
Children born after female eggs were matured in the laboratory are healthy, according to the first survey of babies born using this technique. Since 1997 doctors at the Fertility Clinic in Herlev, Denmark, have been helping women to have babies using a technique called in vitro maturation. This involves taking immature oocytes (eggs) from the... view more... (2003-06-27)
UK researchers raise hopes of preserving fertility for women with cancer
UK fertility experts have sounded a note of cautious optimism about the safety of preserving ovarian tissue and transplanting it back into women after cancer treatment. The optimism follows research reported today (Thursday 27 September) in Human Reproduction*, Europe's leading journal of reproductive medicine. It is the first reported non-test... view more... (2001-09-23)
Underutilized treatment for advanced ovarian cancer found to significantly improve survival
According to a study published in the January 5 issue of the New England Journal of Medicine, women with Stage III ovarian cancer given a combination of intravenous (IV) and intra-abdominal chemotherapy, following the successful surgical removal of tumors, experienced a median survival time 16 months longer than women who received IV chemotherapy... view more... (2006-01-05)
Glypican-3 gene function in regulating body size helps inform novel cancer treatments
In a leading study that has implications for the development of novel therapies for a number of breast, lung and ovarian cancers that have lost the expression of a gene called glypican-3 (GPC3), Sunnybrook researchers have discovered how the loss of the GPC3 gene induces overgrowth through certain growth factors such as Sonic Hedgehog which... view more... (2008-05-13)
RNA splicing factor implicated in ovarian tumor cell growth
An RNA-binding protein that is overproduced in ovarian cancer may present a new target for diagnosis or treatment of ovarian and other cancers, according to researchers at the University of Illinois at Chicago. view more (2007-04-10)
Stimulation helps elderly people with dementia
Multi-Sensory Stimulation (MSS) and structured activity sessions are effective therapies for elderly people with dementia. They could also help to make the ward environment a more pleasant place for patients and staff. These are the conclusions made today, Friday 23 March, in an article in the British Journal of Clinical Psychology by Professor... view more... (2001-03-21)
VEGF Trap shows activity in patients with advanced ovarian cancer
Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy agents. view more (2007-06-04)
Study reveals why certain ovarian cancers develop resistance to platinum-based chemotherapy
A team of researchers led by Fred Hutchinson Cancer Research Center has identified a new mechanism that explains why some recurrent ovarian tumors become resistant to treatment with commonly used platinum-based chemotherapy drugs such as cisplatin and carboplatin. They describe their research online Feb. 10 in the journal Nature. view more (2008-02-11)
Dopamine agonist can prevent ovarian hyperstimulation syndrome in IVF patients
A class of drug widely used in a number of gynaecological conditions can prevent ovarian hyperstimulation syndrome (OHSS), an infrequent but serious complication of assisted reproduction treatments. view more (2006-06-22)
Computer-Assisted Detection Of Proteomic Pattern Could Help Screening For Ovarian Cancer
Issue 16 February 2002 - Early Web Publication: Friday 8 February 2002 A sensitive and non-invasive computer-assisted technique which assesses proteomic patterns in blood could be a step towards effective screening for ovarian cancer, conclude authors of a fast-track study published on The Lancet website this week.* New technologies for the... view more... (2002-02-06)
Nanoparticle-delivered 'suicide' genes slowed ovarian tumor growth
Nanoparticle delivery of diphtheria toxin-encoding DNA selectively expressed in ovarian cancer cells reduced the burden of ovarian tumors in mice, and researchers expect this therapy could be tested in humans within 18 to 24 months, according to a report in Cancer Research, a journal of the American Association for Cancer Research. view more (2009-07-30)
Dormant cancer cells rely on cellular self-cannibalization to survive
A single tumor-suppressing gene is a key to understanding, and perhaps killing, dormant ovarian cancer cells that persist after initial treatment only to reawaken years later, researchers at The University of Texas M. D. Anderson Cancer Center report in the December Journal of Clinical Investigation. view more (2009-01-05)
Promising new treatment option for women with recurrent ovarian cancer
Combining the new drug trabectedin with pegylated liposomal doxorubicin provides clinical benefit to women with relapsed ovarian cancer, according to new results presented at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm. view more (2008-09-16)
The role of hormones in ovarian and endometrial cancers
High levels of the growth factor IGF-I can indicate increased risk of ovarian cancer before the age of 55. This is a finding put forward in a dissertation from Annekatrin Lukanova, Ume'å University, Sweden. The main objective of her thesis was to examine the relationship of pre-diagnostic circulating levels of sex-steroids (androgens and... view more... (2004-04-15)
|
|
| Page
3 of
20 |
381 Results |
|
|
|
Sort By:
Page Views | Date |
|
